Table 1 organizes recent studies investigating the use of GLP analogs and DPP-IV inhibitors in IBD by study design, treatment arm, key results, and evidence classification with risk-of-bias assessment
Registered nurses do not compound, mix, combine, dilute, reconstitute, alter, or add ingredients or additives to IV bags, syringes, vials, or sterile products
The combination or concurrent use of Semaglutide and Wellbutrin in clinical practice raises important questions about the potential synergies and considerations in treating patients with overlapping conditions such as depression and obesity or diabetes
GLP-1 RAs can have some side effects, which are mostly related to the digestive system